System and method for visually presenting digital patient information for future drug use resulting from dosage alteration

• US 20050149362A1
• Filed: 12/30/2003
• Published: 07/07/2005
• Est. Priority Date: 12/30/2003
• Status: Abandoned Application

• Current Assignee: Johnson & Johnson Pharmaceutical Research & Development LLC (Johnson & Johnson)
• Original Assignee: Johnson & Johnson Pharmaceutical Research & Development LLC (Johnson & Johnson)
• Inventors: Alligood, Jacqueline, Schindler, Mark B., Myers, Scott D., Peterson, Per A., Shen-Hsieh, Angela
• Application Number:
  US10/748,081
• Publication Number:
  US 20050149362A1
• Time in Patent Office: Days
• US Class Current: 705/3
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage

Abstract

This invention provides a system and method of visually presenting future drug use in a subject where the subject'"'"'s usage of a drug is altered. The invention comprises selecting a drug associated with Digital Patient Information (DPI). Risk periods associated with the future drug usage period are also displayed.

Claims

1. A method of visually presenting future drug use resulting from altered usage in a subject comprising:

selecting at least one drug associated with a predetermined digital patient information;

identifying a first start time for administering at least one drug dosage;

determining an initial future drug usage period from the digital patient information and the first start time;

identifying at least one subsequent start time for administering at least one subsequent drug dosage, said subsequent start time being a function of an alteration in the subject'"'"'s future drug usage; and

determining a subsequent future drug usage period from the digital patient information and the at least one subsequent start time.

2. The method of claim 1 wherein the method further comprises:

visually presenting on a computer display the initial future drug usage period.

3. The method of claim 1 wherein the method further comprises:

visually presenting the subsequent future drug usage period on a computer display.

4. The method of claims 2 or 3 wherein the visual presentation of the periods are in the form of a calendar.

5. The method of claim 4 wherein the calendar is a linear calendar.

6. The method of claim 1 wherein the method further comprises:

storing in a memory a drug state data for at least one subject'"'"'s drug usage.

7. The method of claim 6 wherein the memory is remotely located.

8. The method of claim 6 wherein the at least one subject'"'"'s drug state data is accessible by at least one party.

9. The method of claim 8 wherein the at least one party offers at least one recommendation based on the drug state data.

10. The method of claim 9 wherein:

the at least one party comprises a pharmaceutical company; and

the pharmaceutical company recommends purchases of pharmaceutical products.

11. The method of claim 8 where the at least one subject'"'"'s drug state data is grouped by the subject'"'"'s characteristics.

12. The method of claim 10 wherein the subject'"'"'s characteristics comprises a designation of a family relationship.

13. The method of claim 8 wherein the at least one party comprises at least one of:

a pharmaceutical company;

a health care professional;

a health management organization;

an insurance company;

a caretaker;

a party authorized to access the subject'"'"'s drug state data;

or

a family member of the subject.

14. The method of claim 1 wherein the digital patient information further comprises educational information about the at least one drug.

15. The method of claim 14 wherein the educational information includes instructions to aid in administering the at least one drug to the subject.

16. The method of claim 15 wherein the method further comprises:

identifying a specific issue to be addressed by visually presenting the instructions.

17. The method of claim 16 wherein the at least one drug is a contraceptive delivered to the subject in the form of a patch and the specific issue to be addressed includes:

the patch being off or partially off a subject for a predetermined time period, said patch having been previously applied to the subject;

not changing the patch within a predetermined time period, said patch having been previously applied to the subject;

not removing the patch from the subject at a predetermined time period, said patch having been previously applied to the subject not administering a first patch on a required start date;

or

correctly applying the patch to the skin of a subject.

18. The method of claim 1 wherein the drug for the initial future drug usage period and the subsequent future drug usage period are different.

19. The method of claim 1 wherein the drug for the initial future drug usage period and the subsequent drug usage period are the same.

20. A method of visually presenting future drug use resulting from altered usage in a subject comprising:

selecting at least one drug associated with a predetermined digital patient information;

identifying at least one start time for administering a dosage of the at least one drug;

determining a future drug usage period from the digital patient information and the at least one start time;

determining a risk period from the digital patient information and the at least one start time, said risk period being associated with the at least one future drug usage period

21. The method of claim 20 wherein them method further comprises:

visually presenting the risk period associated with at least one future drug use period on a computer display.

22. The method of claim 20 wherein the digital patient information further comprises educational information about the at least one drug.

23. The method of claim 22 wherein the educational information includes information about at least one risk associated with the at least one drug.

24. The method of claim 23 wherein the at least one risk includes:

at least one contra-indicated drug;

at least one side-effect;

or

at least one risk related to at least one physical condition of the subject.

25. The method of claim 23 wherein the at least one risk is associated with the risk period.

26. The method of claim 25 wherein:

the at least one drug is a contraceptive delivered to the subject in the form of a patch; and

the risk period is associated with a risk of pregnancy.

31. The system of claim 26 wherein said calendar is a linear calendar.

27. A system for visually presenting future drug use resulting from altered usage in a subject comprising:

a computer executable program;

a program memory for storing digital patient information;

the program, when executed by a processor, being structured to;

accept, via an input, data identifying at least one drug associated with the digital patient information;

accept, via the input, a first start time for at least one drug dosage;

determine an initial future drug usage period from the digital patient information and the first start time;

accept via the input data identifying at least one subsequent start time for at least one subsequent drug dosage;

said subsequent start time being a function of altered drug use in a subject; and

determine a subsequent future drug usage period from the digital patient information and the at least one subsequent start time.

28. The system of claim 27 wherein the program, when executed by a processor, is further structured to:

transmit via an output to a display a visual presentation of the initial future drug usage period.

29. The system of claim 27 wherein the program, when executed by a processor, is further structured to:

transmit via an output to a display a visual presentation of the subsequent future drug usage period.

30. The system of claim 28 or 29 wherein the visual presentation of the periods are displayed in a calendar format.

32. The system of claim 27 wherein the program, when executed by a processor, is further structured to:

store drug state data for at least one subject'"'"'s drug usage in a memory.

33. The system of claim 32 wherein the memory is in a secure environment.

34. The system of claim 32 wherein the memory is remotely located.

35. The system of claim 32 wherein the at least one subject'"'"'s drug state data is accessible by at least one party.

36. The system of claim 32 where the at least one subject'"'"'s drug state data is grouped by the subject'"'"'s characteristics.

37. The system of claim 36 wherein the subjects'"'"' characteristics comprises a designation of a family relationship.

38. The system of claim 35 wherein the at least one party comprises at least one of:

a pharmaceutical company;

a health care professional;

a health management organization;

an insurance company;

a caretaker;

an party authorized to access the subject'"'"'s drug state data;

or

a family member of the subject.

39. The system of claim 35 wherein the at least one party offers recommendations based on the drug state data.

40. The system of claim 38 wherein;

the at least one party comprises a company offering pharmaceuticals; and

the company offering pharmaceuticals recommends purchases of pharmaceutical products.

41. The system of claim 27 wherein the digital patient information further comprises educational information about the at least one drug.

42. The system of claim 41 wherein the program, when executed by a processor, is further structured to:

transmit via the output to the display a visual presentation of the educational information from the digital patient information.

43. The system of claim 41 wherein the educational information includes instructions to aid in administering the at least one drug to the subject the method.

44. The system of claim 43 wherein the program, when executed by a processor, is further structured to:

accept via the input data identifying a specific issue to be addressed by visually presenting the instructions.

45. The system of claim 44 wherein the at least one drug is a contraceptive delivered to a subject in the form of a patch and the specific issue to be addressed includes:

the patch being off or partially off the subject for a predetermined time period, said patch having been previously applied to the subject;

not changing the patch within the predetermined time period;

not administering a first patch on a required start time;

not removing the patch from the subject at a predetermined time period, said patch having been previously applied to the subject;

or

correctly applying the patch to the skin of the subject.

46. The system of claim 27 wherein the program is structured to be executed by a processor in at least one of:

a personal computer;

a personal digital assistant;

a cell phone;

a kiosk;

a digital watch;

or

a drug dispensing device.

47. The system of claim 42 wherein the visual presentation is in the form of a multi-media presentation.

48. The system of claim 47 wherein the a multi-media presentation includes at least one of:

a video presentation;

pop-up windows;

an audio presentation;

at least one animated graphic;

or

hyperlinks to the “

internet”

.

49. The system of claim 27 wherein the program is stored on computer executable media.

50. The system of claim 49 wherein the computer executable media comprises:

at least one compact disc;

at least one memory card;

or

at least one diskette.

51. The system of claim 27 wherein the program is transmitted via the internet.

52. The system of claim 27 wherein the at least one drug for the initial future drug use period and the subsequent drug use period is different.

53. The system of claim 27 wherein the drug for the initial future drug use period and the subsequent future drug use period is the same.

54. A system for visually presenting future drug use resulting from altered usage in a subject comprising:

a computer executable program;

a program memory for storing digital patient information;

the program, when executed by a processor, being structured to;

accept, via an input, data identifying the at least one drug associated with the digital patient information;

accept, via the input, at least one start time for at least one drug dosage;

determine at least one future drug usage period from the digital patient information and the at least one first start time; and

determine a risk period from the digital patient information and at least one start time, said risk period being associated with the at least one future drug usage period.

55. The system of claim 54 wherein the program, when executed by a processor, is further structured to:

transmit via the output to the display a visual presentation of the risk period associated with the at least one future drug use period.

56. The system of claim 54 wherein the digital patient information further comprises educational information about the at least one drug.

57. The system of claim 56 wherein the educational information includes information about at least one risk associated with the at least one drug.

58. The system of claim 57 wherein the at least one risk is associated with the risk period.

59. The system of claim 58 wherein the at least one risk includes:

at least one contra-indicated drug;

at least one side-effect;

or

at least one risk related to a physical condition of the subject.

60. The system of claim 58 wherein:

the at least one drug is a contraceptive delivered to the subject in the form of a patch; and

the risk period is associated with a risk of pregnancy.